MMR -

MMWR Booster for: Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022, Weekly / November 18, 2022 / 71(46);1465–1470

Posted on January 11, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways 1. PRIORIX, a new MMR (Measles, Mumps, and Rubella) vaccine, has been licensed and recommended by the Advisory Committee on Immunization Practices (ACIP) in the United States

Epidemiology, Broadly Speaking

Tag: MMR